149 related articles for article (PubMed ID: 10717526)
1. Expression of telomerase component genes in hepatocellular carcinomas.
Takahashi S; Kitamoto M; Takaishi H; Aikata H; Kawakami Y; Nakanishi T; Shimamoto F; Tahara E; Tahara H; Ide T; Kajiyama G
Eur J Cancer; 2000 Mar; 36(4):496-502. PubMed ID: 10717526
[TBL] [Abstract][Full Text] [Related]
2. Expression of telomerase-associated protein 1 and telomerase reverse transcriptase in hepatocellular carcinoma.
Toshikuni N; Nouso K; Higashi T; Nakatsukasa H; Onishi T; Kaneyoshi T; Kobayashi Y; Kariyama K; Yamamoto K; Tsuji T
Br J Cancer; 2000 Feb; 82(4):833-7. PubMed ID: 10732755
[TBL] [Abstract][Full Text] [Related]
3. Telomerase reverse transcriptase gene amplification in hepatocellular carcinoma.
Takuma Y; Nouso K; Kobayashi Y; Nakamura S; Tanaka H; Matsumoto E; Fujikawa T; Suzuki M; Hanafusa T; Shiratori Y
J Gastroenterol Hepatol; 2004 Nov; 19(11):1300-4. PubMed ID: 15482538
[TBL] [Abstract][Full Text] [Related]
4. Real-time quantification of human telomerase reverse transcriptase mRNA in liver tissues from patients with hepatocellular cancer and chronic viral hepatitis.
Satra M; Gatselis N; Iliopoulos D; Zacharoulis D; Dalekos GN; Tsezou A
J Viral Hepat; 2007 Jan; 14(1):41-7. PubMed ID: 17212643
[TBL] [Abstract][Full Text] [Related]
5. Telomerase activity, telomere length and human telomerase reverse transcriptase expression in hepatocellular carcinoma is independent of hepatitis virus status.
Saini N; Srinivasan R; Chawla Y; Sharma S; Chakraborti A; Rajwanshi A
Liver Int; 2009 Sep; 29(8):1162-70. PubMed ID: 19627485
[TBL] [Abstract][Full Text] [Related]
6. Telomerase reverse transcriptase mRNA expression and telomerase activity in hepatocellular carcinoma.
Nagao K; Tomimatsu M; Endo H; Hisatomi H; Hikiji K
J Gastroenterol; 1999 Feb; 34(1):83-7. PubMed ID: 10204615
[TBL] [Abstract][Full Text] [Related]
7. Telomerase activity in human hepatocellular carcinoma: parallel correlation with human telomerase reverse transcriptase (hTERT) mRNA isoform expression but not with cell cycle modulators or c-Myc expression.
Chen CJ; Tsai NM; Liu YC; Ho LI; Hsieh HF; Yen CY; Harn HJ
Eur J Surg Oncol; 2002 Apr; 28(3):225-34. PubMed ID: 11944954
[TBL] [Abstract][Full Text] [Related]
8. Molecular analysis of PinX1 in human hepatocellular carcinoma.
Oh BK; Chae KJ; Park C; Park YN
Oncol Rep; 2004 Oct; 12(4):861-6. PubMed ID: 15375513
[TBL] [Abstract][Full Text] [Related]
9. Quantitative assessment of hTERT mRNA expression in dysplastic nodules of HBV-related hepatocarcinogenesis.
Oh BK; Kim YJ; Park YN; Choi J; Kim KS; Park C
Am J Gastroenterol; 2006 Apr; 101(4):831-8. PubMed ID: 16494581
[TBL] [Abstract][Full Text] [Related]
10. Cellular distribution of telomerase reverse transcriptase in human hepatocellular carcinoma.
Onishi T; Nouso K; Higashi T; Toshikuni N; Nakatsukasa H; Kobayashi Y; Uemura M; Yumoto E; Fujiwara K; Sato S; Nakamura S; Yokoyama J; Hanafusa T; Shiratori Y
J Gastroenterol Hepatol; 2003 Oct; 18(10):1168-74. PubMed ID: 12974904
[TBL] [Abstract][Full Text] [Related]
11. Telomeric 3' overhangs in chronic HBV-related hepatitis and hepatocellular carcinoma.
Lee JE; Oh BK; Choi J; Park YN
Int J Cancer; 2008 Jul; 123(2):264-272. PubMed ID: 18449889
[TBL] [Abstract][Full Text] [Related]
12. Abnormal expression of hepatomas and circulating telomerase and its clinical values.
Wu W; Yao DF; Qiu LW; Wu XH; Yao M; Su XQ; Zou L
Hepatobiliary Pancreat Dis Int; 2005 Nov; 4(4):544-9. PubMed ID: 16286259
[TBL] [Abstract][Full Text] [Related]
13. PCR and in situ hybridization studies of telomerase subunits in human non-neoplastic livers.
Harada K; Yasoshima M; Ozaki S; Sanzen T; Nakanuma Y
J Pathol; 2001 Feb; 193(2):210-7. PubMed ID: 11180168
[TBL] [Abstract][Full Text] [Related]
14. Sensitive detection of human telomerase reverse transcriptase mRNA in the serum of patients with hepatocellular carcinoma.
Miura N; Shiota G; Nakagawa T; Maeda Y; Sano A; Marumoto A; Kishimoto Y; Murawaki Y; Hasegawa J
Oncology; 2003; 64(4):430-4. PubMed ID: 12759542
[TBL] [Abstract][Full Text] [Related]
15. Human telomerase reverse transcriptase messenger RNA (TERT mRNA) as a tumour marker for early detection of hepatocellular carcinoma.
El-Mazny A; Sayed M; Sharaf S
Arab J Gastroenterol; 2014 Jun; 15(2):68-71. PubMed ID: 25097049
[TBL] [Abstract][Full Text] [Related]
16. Leptin as a critical regulator of hepatocellular carcinoma development through modulation of human telomerase reverse transcriptase.
Stefanou N; Papanikolaou V; Furukawa Y; Nakamura Y; Tsezou A
BMC Cancer; 2010 Aug; 10():442. PubMed ID: 20723213
[TBL] [Abstract][Full Text] [Related]
17. [Expression of telomerase reverse transcriptase and its relationship with tumor suppressor gene p53 in HCC].
Dai D; Zhai W; Zhu T; Zhu H; Ling Y
Zhonghua Gan Zang Bing Za Zhi; 2001 Jul; 9 Suppl():79-81. PubMed ID: 11509149
[TBL] [Abstract][Full Text] [Related]
18. Modulation of human telomerase reverse transcriptase in hepatocellular carcinoma.
Chen CJ; Kyo S; Liu YC; Cheng YL; Hsieh CB; Chan DC; Yu JC; Harn HJ
World J Gastroenterol; 2004 Mar; 10(5):638-42. PubMed ID: 14991929
[TBL] [Abstract][Full Text] [Related]
19. Serum human telomerase reverse transcriptase messenger RNA as a novel tumor marker for hepatocellular carcinoma.
Miura N; Maeda Y; Kanbe T; Yazama H; Takeda Y; Sato R; Tsukamoto T; Sato E; Marumoto A; Harada T; Sano A; Kishimoto Y; Hirooka Y; Murawaki Y; Hasegawa J; Shiota G
Clin Cancer Res; 2005 May; 11(9):3205-9. PubMed ID: 15867214
[TBL] [Abstract][Full Text] [Related]
20. High telomerase activity and long telomeres in advanced hepatocellular carcinomas with poor prognosis.
Oh BK; Kim H; Park YN; Yoo JE; Choi J; Kim KS; Lee JJ; Park C
Lab Invest; 2008 Feb; 88(2):144-52. PubMed ID: 18158557
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]